CIBC Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

CIBC Asset Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-547,084	Closed	-$18.6M	–	1619
2021 Q3	$18.6M	Buy	547,084 +259	+0%	+$8.27K	0.07%	160
2021 Q2	$20M	Buy	+546,825	New	+$21.2M	0.08%	146
2019 Q4	–	Sell	-78,371	Closed	-$2.66M	–	1252
2019 Q3	$2.66M	Sell	78,371 -12,771	-14%	-$378K	0.02%	371
2019 Q2	$2.06M	Buy	91,142 +49,884	+121%	+$1.17M	0.01%	429
2019 Q1	$958K	Buy	+41,258	New	+$1.08M	0.01%	608

Other funds holding DCPH

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CIBC Asset Management's DCPH Position: Q4 2021 in Review

CIBC Asset Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 547,084 shares — an estimated $18.6M sold.

CIBC Asset Management first reported a position in DCPH in Q1 2019 and held it in 5 quarters. The position peaked at $20M in Q2 2021. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

CIBC Asset Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
CIBC Asset Management sold 547,084 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $18.6M.
CIBC Asset Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2019 and held it in 5 quarters.
CIBC Asset Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $20M in Q2 2021.
140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on CIBC Asset Management's 13F filing for Q4 2021, filed 8 Feb 2022.